Beijing HyperStrong Technology
688411
Yalian Machinery
001395
Merit Interactive
300766
Pansoft
300996
Sublime China Information
301299
CN Stock MarketDetailed Quotes
600572 Zhejiang Conba Pharmaceutical
- 4.54
- +0.05+1.11%
Market Closed Jan 27 15:00 CST
11.73BMarket Cap24.15P/E (TTM)
4.60High4.49Low235.78KlotVolume4.49Open4.49Pre Close107.43MTurnover0.92%Turnover Ratio19.83P/E (Static)2.58BShares5.5452wk High1.75P/B11.70BFloat Cap3.8752wk Low4.94Limit Up2.58BShs Float12.13Historical High4.04Limit Down2.45%Amplitude-0.82Historical Low0.20Dividend TTM4.56Avg Price105.84KlotAsk4.41%Div YieldTTM100Lot Size123.64KlotBid
Zhejiang Conba Pharmaceutical News
Connbay: Announcement on the results of independent exercise of the stock options incentive plan for the fourth quarter of 2024 and stock changes
Announcement on independent exercise results and share changes of the stock options incentive plan for the fourth quarter of 2024
Implementation Notice on the 2022 Stock Options Incentive Plan to grant independent exercise of stock options for the first time during the first exercise period
Announcement on the completion of cancellation of some stock options granted for the first time in the 2022 Stock Options Incentive Plan
Conn Bay: Announcement on the 2022 Stock Options Incentive Plan for the first time granting stock options for the first exercise period to meet the conditions for exercising
Conn Bay: Explanation of the company\'s board of directors on the successive adjustments of incentives and incentive amounts
Conn Bay: Supervisory Board\'s Review Opinions on the 2022 Stock Options Incentive Plan for the First Time Granting of Feasible Right Incentive Targets for Stock Options for the First Time
Conn Bay: Announcement on Cancelling Some Stock Options Granted for the First Time in the 2022 Stock Options Incentive Plan
Conn Bei: Legal Opinion of Shanghai Oriental Huayin Law Firm on the fulfilment of the enforcement conditions of Conn Bay\'s 2022 Stock Options Incentive Plan and cancellation of some options
Legal Opinion of Shanghai Oriental Huayin Law Firm on the Fulfilment of Terms and Cancellation of Some Options of Conn Bay\'s 2022 Stock Options Incentive Plan
Announcement on cancellation of some stock options granted in the 2022 Stock Options Incentive Plan for the first time
Announcement on the 2022 Stock Options Incentive Plan for the first time granting stock options for the first exercise period to meet the conditions for exercise
Board of Supervisors Review Opinions on the 2022 Stock Options Incentive Plan for the First Time Granting of Feasible Right Incentive Targets for Stock Options for the First Time
Announcement on the implementation results of the plan for the controlling shareholder to increase the shareholding of the company
Zhejiang Conba Pharmaceutical: Legal opinion on the adjustment of exercise price of stock options incentive plan of Zhejiang Conba Pharmaceutical in 2022.
Zhejiang Conba Pharmaceutical: Announcement Regarding the Adjustment of the Stock Option Exercise Price of the Stock Option Incentive Plan for 2022.
Announcement on the progress of repurchasing the company's shares through centralized bidding trade.
Announcement Regarding the Pledge of Shares Held by Company Shareholders
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Announcement on the implementation of the company's 2023 equity allocation
